Physician profile
Gary E Quinby
NPI 1780655936
$918.10
in general payments reported to CMS, 2019-2025
10 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $99.99 · 2023: $400 · 2024: $311 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $802.84 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $322.45 | 2023-2025 | |
| Lilly USA, LLC | $243.65 | 2023-2024 | Taltz, Olumiant |
| Janssen Biotech, INC. | $99.99 | 2020 | |
| Dermavant Sciences, INC. | $96.91 | 2024 | Vtama |
| Ucb, INC. | $72.17 | 2023-2025 | Bimzelx, Cimzia |
| E.R. Squibb & Sons, L.L.C. | $19.81 | 2024 | Sotyktu |
| Organogenesis INC. | $16.72 | 2023 | Puraply |
| Amgen INC. | $16.08 | 2025 | Otezla |
| Pfizer INC. | $15.27 | 2023 | |
| Convatec INC. | $15.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Quinby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.